4.7 Article

Steroid treatment suppresses the CD4+ T-cell response to the third dose of mRNA COVID-19 vaccine in systemic autoimmune rheumatic disease patients

Related references

Note: Only part of the references are listed.
Article Rheumatology

Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients

Yael Pri-Paz Basson et al.

Summary: This study evaluated the immunogenicity and safety of the second dose of the Pfizer/BioNTech mRNA vaccine in patients with SARDs, finding a decline in immunogenicity, especially in patients treated with immunosuppressants. Adverse effects of the vaccine may indicate the development of immunity in these patients.

CLINICAL RHEUMATOLOGY (2022)

Article Cell Biology

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients

Anthony T. Tan et al.

Summary: This study found that early induction of interferon-gamma (IFN-gamma) secreting SARS-CoV-2-specific T cells was present in patients with mild disease and accelerated viral clearance, while rapid induction and quantity of humoral responses were associated with an increase in disease severity. These findings highlight the importance of early functional SARS-CoV-2-specific T cells in both vaccine design and immune monitoring.

CELL REPORTS (2021)

News Item Medicine, General & Internal

Covid-19: Pfizer vaccine provides 90% protection against infection in children aged 5-11, study finds

Jacqui Wise

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Rheumatology

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression

Maria Prendecki et al.

Summary: SARS-CoV-2 vaccines are immunogenic in patients receiving immunosuppression, though the response is impaired compared to healthy individuals. B-cell depletion following rituximab impairs serological responses, but T-cell responses are preserved in this group. Repeat vaccine doses for serological non-responders could be considered to induce more robust immunological response.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Rheumatology

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Victoria Furer et al.

Summary: Vaccination with mRNA BNT162b2 vaccine showed reduced immunogenicity in patients with AIIRD compared to the general population, with risk factors including older age and treatment with glucocorticoids, rituximab, mycophenolate mofetil (MMF), and abatacept. However, most patients maintained stable disease activity post-vaccination.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Letter Medicine, General & Internal

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

Ilies Benotmane et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Multidisciplinary Sciences

Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'

David S. Fischer et al.

Summary: This study used single-cell RNA sequencing to identify the phenotypic profile of SARS-CoV-2-reactive T cells, inducing transcriptional shifts by in vitro antigenic stimulation and revealing phenotypic effects introduced by antigen-specific stimulation. The results show that reverse phenotyping can provide an integrated insight into the cellular states of SARS-CoV-2-reactive T cells across tissues and activation states.

NATURE COMMUNICATIONS (2021)

Article Immunology

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2

Benjamin Israelow et al.

Summary: Research demonstrates that both humoral and cellular immunity play a role in clearing SARS-CoV-2, and convalescent mice or mice vaccinated with mRNA are protected from infection with both the wild type virus and the B.1.351 variant. This protection is mainly mediated by antibody response rather than cellular immunity.

SCIENCE IMMUNOLOGY (2021)

Review Immunology

The CD83 Molecule - An Important Immune Checkpoint

Linda Grosche et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Ugur Sahin et al.

NATURE (2020)

Article Medicine, General & Internal

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

E. J. Anderson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Immunology

Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses

Luis M. Franco et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Review Biochemistry & Molecular Biology

A gradient of glucocorticoid sensitivity among helper T cell cytokines

Jesus Banuelos et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2016)

Article Biochemistry & Molecular Biology

Immunity-related GTPase M (IRGM) Proteins Influence the Localization of Guanylate-binding Protein 2 (GBP2) by Modulating Macroautophagy

Maria K. Traver et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Transcription factor NF-κB regulates inducible CD83 gene expression in activated T lymphocytes

TA McKinsey et al.

MOLECULAR IMMUNOLOGY (2000)